Newswise — Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, offering patients an alternative to open heart surgery. Over the last decade, there has been a dramatic shift in the treatment of valvular heart disease, and today, the majority of patients with aortic stenosis who undergo aortic valve replacement have a TAVR procedure.
A new study led by Yale investigators demonstrated that patients with severe aortic stenosis treated with TAVR have comparable five-year outcomes to those treated with surgical aortic valve replacement (SAVR). The study was published in the Journal of the American College of Cardiology (JACC) on March 30, 2025, and was presented as a late-breaking study at the 2025 American College of Cardiology…